Skip to content

Professor Andrew David DickB.Sc., M.B.B.S.(Lond.), M.D.(Aberd.), M.R.C.P.(UK), F.R.C.S.(Lond.), F.R.C.S.(Edin.), F.R.C.P.(Edin.), F.R.C.Ophth, FMedSci

Professor of Ophthalmology

21 - 30 out of 255Page size: 10
  1. 2018
  2. Published

    Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III

    Suhler, E. B., Adán, A., Brézin, A. P., Fortin, E., Goto, H., Jaffe, G. J., Kaburaki, T., Kramer, M., Lim, L. L., Muccioli, C., Nguyen, Q. D., Van Calster, J., Cimino, L., Kron, M., Song, A. P., Liu, J., Pathai, S., Camez, A., Schlaen, A., van Velthoven, M. E. J., Vitale, A. T., Zierhut, M., Tari, S. & Dick, A. D., 1 Jul 2018, In : Ophthalmology. 125, 7, p. 1075-1087 13 p.

    Research output: Contribution to journalArticle

  3. Published

    Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error

    The CREAM Consortium, the 23 and Me Research Team, UK Biobank Eye and Vision Consortium & Tedja, M. S., Jun 2018, In : Nature Genetics. 50, 6, p. 834-848 15 p.

    Research output: Contribution to journalArticle

  4. Published

    Autoimmunity, Autoinflammation, and Infection in Uveitis

    Forrester, J. V., Kuffova, L. & Dick, A. D., 1 May 2018, In : American Journal of Ophthalmology. 189, p. 77-85 9 p.

    Research output: Contribution to journalArticle

  5. Published

    Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative

    Fundamentals of Care for Uveitis International Consensus Group, 1 May 2018, In : Ophthalmology. 125, 5, p. 757-773 17 p.

    Research output: Contribution to journalArticle

  6. Published

    C-reactive protein as a therapeutic target in age-related macular degeneration

    Molins, B., Romero-Vázquez, S., Fuentes-Prior, P., Adan, A. & Dick, A. D., 19 Apr 2018, In : Frontiers in Immunology. 9, APR, 9 p., 808.

    Research output: Contribution to journalArticle

  7. Published

    Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis

    Makragiannis, G., Vahdani, K., Carreño, E., Lee, R. W. J., Dick, A. D. & Ross, A. H., 1 Apr 2018, In : International Ophthalmology. 38, 2, p. 781-785 5 p.

    Research output: Contribution to journalArticle

  8. Published

    Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial

    Rajendram, R., Taylor, P. N., Wilson, V. J., Harris, N., Morris, O. C., Tomlinson, M., Yarrow, S., Garrott, H., Herbert, H. M., Dick, A. D., Cook, A., Gattamaneni, R., Jain, R., Olver, J., Hurel, S. J., Bremner, F., Drummond, S. R., Kemp, E., Ritchie, D. M., Rumsey, N., Morris, D., Lane, C., Palaniappan, N., Li, C., Pell, J., Hills, R., Ezra, D. G., Potts, M. J., Jackson, S., Rose, G. E., Plowman, N., Bunce, C., Uddin, J. M., Lee, R. W. J. & Dayan, C. M., 1 Apr 2018, In : Lancet Diabetes and Endocrinology. 6, 4, p. 299-309 11 p.

    Research output: Contribution to journalArticle

  9. E-pub ahead of print

    Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review

    Leal, I., Rodrigues, F. B., Sousa, D. C., Romão, V. C., Duarte, G. S., Carreño, E., Dick, A. D., Marques-Neves, C., Costa, J. & Fonseca, J. E., 25 Mar 2018, In : Acta Ophthalmologica.

    Research output: Contribution to journalReview article

  10. Published

    Automated quantification of retinal vessel morphometry in the UK biobank cohort

    on behalf of the UK Biobank Eye and Vision Consortium, 8 Mar 2018, Proceedings of the 7th International Conference on Image Processing Theory, Tools and Applications, IPTA 2017. Institute of Electrical and Electronics Engineers (IEEE), Vol. 2018-January. p. 1-6 6 p.

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  11. Published

    A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)

    APTITUDE Trial Management Group, 27 Feb 2018, In : BMC rheumatology. 2, 4, 9 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...26 Next